| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Urology, Klinikum Benjamin Franklin, Freie Universität Berlin, D-12200 Berlin, Germany
Promoter hypermethylation of the glutathione S-transferase P1 gene (GSTP1) is the most frequent DNA alteration in prostatic carcinoma. Because this epigenetic DNA alteration can be reliably detected by methylation-specific PCR (MSP), we applied this new technique for molecular detection of prostate cancer in various human bodily fluids. We investigated GSTP1 promoter hypermethylation in DNA isolated from plasma, serum, ejaculate, and urine after prostate massage and from prostate carcinoma tissues from 33 patients with prostate cancer and 26 control patients with benign prostatic hyperplasia (BPH). Fluorescently labeled MSP products were analyzed on an automated gene sequencer. Whereas GSTP1 promoter hypermethylation was not detectable by MSP in prostate tissue and bodily fluids from patients with BPH, we found it in 94% of tumors (16 of 17), 72% of plasma or serum samples (23 of 32), 50% of ejaculate (4 of 8) and 36% of urine (4 of 11) from patients with prostate cancer. Additionally, MSP identified circulating tumor cells in 30% (10 of 33) of prostate cancer patients. Analysis of GSTP1 promoter hypermethylation by MSP thus provides a specific tool for molecular diagnosis of prostate cancer in bodily fluids.
This article has been cited by other articles:
|
|
 |
|
  Y. Korshunova, R. K. Maloney, N. Lakey, R. W. Citek, B. Bacher, A. Budiman, J. M. Ordway, W. R. McCombie, J. Leon, J. A. Jeddeloh, et al. Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA Genome Res., January 1, 2008; 18(1): 19 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Bastian, G. S. Palapattu, S. Yegnasubramanian, X. Lin, C. G. Rogers, L. A. Mangold, B. Trock, M. Eisenberger, A. W. Partin, and W. G. Nelson Prognostic Value of Preoperative Serum Cell-Free Circulating DNA in Men with Prostate Cancer Undergoing Radical Prostatectomy Clin. Cancer Res., September 15, 2007; 13(18): 5361 - 5367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Feng, S. E. Hawes, J. E. Stern, A. Dem, P. S. Sow, B. Dembele, P. Toure, P. Sova, P. W. Laird, and N. B. Kiviat Promoter Hypermethylation of Tumor Suppressor Genes in Urine from Patients with Cervical Neoplasia Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1178 - 1184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Roupret, V. Hupertan, D. R. Yates, J. W.F. Catto, I. Rehman, M. Meuth, S. Ricci, R. Lacave, G. Cancel-Tassin, A. de la Taille, et al. Molecular Detection of Localized Prostate Cancer Using Quantitative Methylation-Specific PCR on Urinary Cells Obtained Following Prostate Massage Clin. Cancer Res., March 15, 2007; 13(6): 1720 - 1725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. U. Bai, A. Kaseb, S. Tejwani, G. W. Divine, E. R. Barrack, M. Menon, A. B. Pardee, and G. P.-V. Reddy Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine PNAS, February 13, 2007; 104(7): 2343 - 2348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S Perry, R. Foley, K. Woodson, and M. Lawler The emerging roles of DNA methylation in the clinical management of prostate cancer. Endocr. Relat. Cancer, June 1, 2006; 13(2): 357 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Urakami, H. Shiina, H. Enokida, T. Kawakami, K. Kawamoto, H. Hirata, Y. Tanaka, N. Kikuno, M. Nakagawa, M. Igawa, et al. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin. Cancer Res., April 1, 2006; 12(7 Pt 1): 2109 - 2116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. O. Hoque, O. Topaloglu, S. Begum, R. Henrique, E. Rosenbaum, W. Van Criekinge, W. H. Westra, and D. Sidransky Quantitative Methylation-Specific Polymerase Chain Reaction Gene Patterns in Urine Sediment Distinguish Prostate Cancer Patients From Control Subjects J. Clin. Oncol., September 20, 2005; 23(27): 6569 - 6575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Enokida, H. Shiina, S. Urakami, M. Igawa, T. Ogishima, L.-C. Li, M. Kawahara, M. Nakagawa, C. J. Kane, P. R. Carroll, et al. Multigene Methylation Analysis for Detection and Staging of Prostate Cancer Clin. Cancer Res., September 15, 2005; 11(18): 6582 - 6588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Miyamoto and T. Ushijima Diagnostic and Therapeutic Applications of Epigenetics Jpn. J. Clin. Oncol., June 1, 2005; 35(6): 293 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Bastian, G. S. Palapattu, X. Lin, S. Yegnasubramanian, L. A. Mangold, B. Trock, M. A. Eisenberger, A. W. Partin, and W. G. Nelson Preoperative Serum DNA GSTP1 CpG Island Hypermethylation and the Risk of Early Prostate-Specific Antigen Recurrence Following Radical Prostatectomy Clin. Cancer Res., June 1, 2005; 11(11): 4037 - 4043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Laird Cancer epigenetics Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R65 - R76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Boddy, S. Gal, P. R. Malone, A. L. Harris, and J. S. Wainscoat Prospective Study of Quantitation of Plasma DNA Levels in the Diagnosis of Malignant versus Benign Prostate Disease Clin. Cancer Res., February 15, 2005; 11(4): 1394 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-C. Li, P. R. Carroll, and R. Dahiya Epigenetic Changes in Prostate Cancer: Implication for Diagnosis and Treatment J Natl Cancer Inst, January 19, 2005; 97(2): 103 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Das and R. Singal DNA Methylation and Cancer J. Clin. Oncol., November 15, 2004; 22(22): 4632 - 4642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Gifford, J. Paul, P. A. Vasey, S. B. Kaye, and R. Brown The Acquisition of hMLH1 Methylation in Plasma DNA after Chemotherapy Predicts Poor Survival for Ovarian Cancer Patients Clin. Cancer Res., July 1, 2004; 10(13): 4420 - 4426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. TABACK, S. J. O'DAY, and D. S.B. HOON Quantification of Circulating DNA in the Plasma and Serum of Cancer Patients Ann. N.Y. Acad. Sci., June 1, 2004; 1022(1): 17 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Muller, A. Widschwendter, H. Fiegl, L. Ivarsson, G. Goebel, E. Perkmann, C. Marth, and M. Widschwendter DNA Methylation in Serum of Breast Cancer Patients: An Independent Prognostic Marker Cancer Res., November 15, 2003; 63(22): 7641 - 7645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nakayama, C. J. Bennett, J. L. Hicks, J. I. Epstein, E. A. Platz, W. G. Nelson, and A. M. De Marzo Hypermethylation of the Human Glutathione S-Transferase-{pi} Gene (GSTP1) CpG Island Is Present in a Subset of Proliferative Inflammatory Atrophy Lesions but Not in Normal or Hyperplastic Epithelium of the Prostate: A Detailed Study Using Laser-Capture Microdissection Am. J. Pathol., September 1, 2003; 163(3): 923 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Gonzalgo, C. P. Pavlovich, S. M. Lee, and W. G. Nelson Prostate Cancer Detection by GSTP1 Methylation Analysis of Postbiopsy Urine Specimens Clin. Cancer Res., July 1, 2003; 9(7): 2673 - 2677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bearzatto, D. Conte, M. Frattini, N. Zaffaroni, F. Andriani, D. Balestra, L. Tavecchio, M. G. Daidone, and G. Sozzi p16INK4A Hypermethylation Detected by Fluorescent Methylation-specific PCR in Plasmas from Non-Small Cell Lung Cancer Clin. Cancer Res., December 1, 2002; 8(12): 3782 - 3787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Johnson and Y.M. D. Lo Plasma Nucleic Acids in the Diagnosis and Management of Malignant Disease Clin. Chem., August 1, 2002; 48(8): 1186 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Virmani, J. A. Tsou, K. D. Siegmund, L. Y. C. Shen, T. I. Long, P. W. Laird, A. F. Gazdar, and I. A. Laird-Offringa Hierarchical Clustering of Lung Cancer Cell Lines Using DNA Methylation Markers Cancer Epidemiol. Biomarkers Prev., March 1, 2002; 11(3): 291 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Y. Chan, L. W. Chan, N. L. S. Tang, J. H. M. Tong, K. W. Lo, T. L. Lee, H. Y. Cheung, W. S. Wong, P. S. F. Chan, F. M. M. Lai, et al. Hypermethylation of Multiple Genes in Tumor Tissues and Voided Urine in Urinary Bladder Cancer Patients Clin. Cancer Res., February 1, 2002; 8(2): 464 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Widschwendter and P. A. Jones The Potential Prognostic, Predictive, and Therapeutic Values of DNA Methylation in Cancer : Commentary re: J. Kwong et al., Promoter Hypermethylation of Multiple Genes in Nasopharyngeal Carcinoma. Clin. Cancer Res., 8: 131-137, 2002, and H-Z. Zou et al., Detection of Aberrant p16 Methylation in the Serum of Colorectal Cancer Patients. Clin. Cancer Res., 8: 188-191, 2002. Clin. Cancer Res., January 1, 2002; 8(1): 17 - 21. [Full Text] [PDF]
|
|
|
|
|
|
C. Jeronimo, H. Usadel, R. Henrique, J. Oliveira, C. Lopes, W. G. Nelson, and D. Sidransky Quantitation of GSTP1 Methylation in Non-neoplastic Prostatic Tissue and Organ-Confined Prostate Adenocarcinoma J Natl Cancer Inst, November 21, 2001; 93(22): 1747 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Lin, M. Tascilar, W.-H. Lee, W. J. Vles, B. H. Lee, R. Veeraswamy, K. Asgari, D. Freije, B. van Rees, W. R. Gage, et al. GSTP1 CpG Island Hypermethylation Is Responsible for the Absence of GSTP1 Expression in Human Prostate Cancer Cells Am. J. Pathol., November 1, 2001; 159(5): 1815 - 1826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. H. N. WONG, Y. M. D. LO, and P. J. JOHNSON Epigenetic Tumor Markers in Plasma and Serum: Biology and Applications to Molecular Diagnosis and Disease Monitoring Ann. N.Y. Acad. Sci., September 1, 2001; 945(1): 36 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. GOESSL, M. MULLER, R. HEICAPPELL, H. KRAUSE, and K. MILLER DNA-Based Detection of Prostate Cancer in Blood, Urine, and Ejaculates Ann. N.Y. Acad. Sci., September 1, 2001; 945(1): 51 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cairns, M. Esteller, J. G. Herman, M. Schoenberg, C. Jeronimo, M. Sanchez-Cespedes, N.-H. Chow, M. Grasso, L. Wu, W. B. Westra, et al. Molecular Detection of Prostate Cancer in Urine by GSTP1 Hypermethylation Clin. Cancer Res., September 1, 2001; 7(9): 2727 - 2730. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
